According to a disclosure contained in the company’s quarterly 10Q filing, the US Department of Justice (DOJ) issued a civil investigation demand to Mylan NV – the manufacturer of EpiPen – over the Trades Agreement Act. The demand was issued by the DOJ’s Commercial Litigation Branch to a Mylan subsidiary regarding compliance for certain products, though the subsidiary, products, and reasons for the investigation were not disclosed.
The Trades Agreement Act of 1979 is an Act of Congress that governs trade agreements negotiated between the United States and other countries.
“The company is fully cooperating with the DOJ,” Mylan said.
The company also disclosed that certain employees of Mylan’s Italian subsidiary were served with search warrants seeking information concerning interactions with an Italian hospital and sales of certain reimbursable drugs. The warrants were issued by the special prosecutor’s office in Milan.
Mylan said it was assisting its employees in their cooperation with the probe, but did not provide details.
Source: Commission File Number 333-199861 MYLAN N.V – Mylan
It is a very sad day when children and adults in this country cannot access such a small dose of medicine
that will save their life. This is a serious matter. As a nurse if my patient starts to have a severe allergic reaction I could be unable to help them.